Accueil / Formation Recherche / Publications / Publications Histiocytoses

Publications Histiocytoses

Highly sensitive methods are required to detect mutations in histiocytoses.

Langerhans Cell Histiocytoma: A Benign Histiocytic Neoplasm of Diverse Lines of Terminal Differentiation.

Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment.

Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.

BRAF V600E mutation detected in a case of Rosai-Dorfman disease.

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Phenotypes and survival in Erdheim-Chester disease: results from a 165-patient cohort


Efficacy of infliximab in the treatment of Erdheim-Chester disease.

How I manage pulmonary Langerhans cell histiocytosis. Lorillon G et al. Eur Respir Rev. 2017 Sep 6;26(145).

Current understanding and management of pulmonary Langerhans cell histiocytosis. Vassallo R et al. Thorax. 2017 Oct;72(10):937-945.

Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study. Tazi A et al.  Orphanet J Rare Dis. 2017 May 22;12(1):95.

New somatic BRAF splicing mutation in Langerhans cell histiocytosis. Héritier S et al. Mol Cancer. 2017 Jul 6;16(1):115.

Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis. Héritier S et al. Br J Haematol. 2017 Aug;178(3):457-467.

Erdheim-Chester disease: the “targeted” revolution. Vaglio A et al. Blood. 2017 Sep 14;130(11):1282-1284.

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Durham BH et al. Blood. 2017 Jul 13;130(2):176-180.

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study). Cohen Aubart F et al. Blood. 2017 Sep 14;130(11):1377-1380.

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis. Papo M et al. Blood. 2017 Aug 24;130(8):1007-1013.

Histiocytoses langerhansienne de l'adulte La Revue de Médecine Interne ; 36(10):658-67 ; Octobre 2015

The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study.


 

ACTUALITÉS

Le Pr Eric Oksenhendler récompensé "Médecin de l'année 2018" pour son travail sur la maladie de Castleman

Le congrès des Rencontres RARE revient pour sa 6ème édition, les 5 & 6 novembre 2019
Cité des Sciences et de l'Industrie, Paris
Ouverture des candidatures pour l'ASH 2019 à Orlando
La filière MaRIH recherche deux internes "reporters" pour participer à l'ASH !
Voir toutes les actualités

AGENDA

Du 27-09-2019 au 29-09-2019 : 16èmes Journées de l’Association des Internes en Hématologie, Lyon


04-10-2019 : 7ème Journée régionale interactive maladies rares immuno-hématologiques MaRIH "Océan Indien", Saint-Denis (La Réunion)


04-10-2019 : Journée annuelle du centre de référence des aplasies médullaires acquises et constitutionnelles, Paris
Voir tout l'agenda